Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • biocomputer
    Member
    • Dec 2013
    • 62

    #1

    ChIP-seq analysis of repetitive sequences, should I remove (PCR) duplicates?

    When I do a normal alignment of paired-end ChIP-seq reads to the full mouse genome I identify PCR duplicates by looking for fragments that have identical coordinates and identical sequences for both forward and reverse reads. Now I'm looking for repetitive sequences by aligning to an index made up of all sequences from the UCSC RepeatMasker track. I'm not sure how or if I should be removing duplicates. It seems like repetitive sequences may be more likely align to the same positions and still be legitimate so I don't think a blanket removal of all these duplicates is the best option.

    I want to compare enrichment at repetitive sequences between multiple samples. Leaving in all duplicates may unfairly increase the magnitude of some changes between samples while removing them all may unfairly decrease some changes. For example, one particular repeat type is decreased in the treatment sample to 0.4 if I leave in duplicates and to 0.7 if I remove them. Maybe the true difference is somewhere in between there? In addition, in some cases the overall level of duplication between control and treatment samples is quite different (eg. 20% vs 30%) and it's hard to know if that's a real difference or not.

    Any ideas about what to do here?

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
13 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Working...